AGE

, Volume 27, Issue 1, pp 39–48

Caloric restriction versus drug therapy to delay the onset of aging diseases and extend life

  • Arthur V. Everitt
  • George S. Roth
  • David G. Le Couteur
  • Sarah N. Hilmer
Review article

Abstract

There are two firmly established methods of prolonging life. Calorie restriction (CR) using nutrient-rich diets to prolong life in lower animals, and life saving medications in humans to delay the development of the major diseases of middle and old age. These two approaches have different mechanisms of action. In rats, CR at 40% below ad libitum intake begun soon after weaning and continued until death, reduces body weight by about 40% and increases lifespan. There have been no lifelong CR studies performed on humans. However, in healthy adult human subjects about 20% CR over a period of 2–15 years, lowers body weight by about 20% and decreases body mass index (BMI) to about 19. This CR treatment in humans reduces blood pressure and blood cholesterol to a similar extent as the specific drugs used to delay the onset of vascular disease and so extend human life. These same drugs may act by mechanisms that overlap with some of the mechanisms of CR in retarding these pathologies and thus may have similar antiaging and life prolonging actions. Such drugs may be regarded as CR mimetics which inhibit the development of certain life shortening diseases, without the need to lower calorie intake. In developed countries, better medical care, drug therapy, vaccinations, and other public health measures have extended human life by about 30 years during the 20th century without recourse to CR, which is so effective in the rat. The percentage gain in human life expectancy during the 20th century is twice that achieved by CR in rat survival. However, rat longevity studies now use specific pathogen-free animals and start CR after weaning or later, thereby excluding deaths from infectious diseases and those associated with birth and early life. There is a need to develop CR mimetics which can delay the development of life-threatening diseases in humans. In the 21st century due to the human epidemic of overeating with a sedentary lifestyle, it may necessary to utilize CR to counter the aging effects of overweight. Since the greatest life-extending effects of CR in the rodent occur when started early in life, long-term antiaging therapy in humans should be initiated soon after maturity, when physiological systems have developed optimally.

Key words

blood pressure calorie restriction mimetics cardiovascular disease cholesterol lifespan medications 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anisimov VN (2003a) Effects of exogenous melatonin – a review. Toxicol Pathol 31: 589–603PubMedGoogle Scholar
  2. Anisimov VN (2003b) Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention. Exp Gerontol 38: 1041–1049CrossRefPubMedGoogle Scholar
  3. Anisimov VN, Semenchenko AV and Yashin AI (2003a) Insulin and longevity: antidiabetic biguanides as geroprotectors. Biogerontology 4: 297–307CrossRefPubMedGoogle Scholar
  4. Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, Alimova IN, Rosenfeld SV, Zavarzina NY, Semenchenko AV and Yashin AI (2003b) Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology 4: 193–200CrossRefPubMedGoogle Scholar
  5. Barbieri M, Bonafe M, Franceschi C and Paolisso G (2003) Insulin/IGF-1-signaling pathway: an evolutionarily conserved mechanism of longevity from yeast to humans. Am J Physiol: Endocrinol Metab 285: E1064–E1071Google Scholar
  6. Barrows CH Jr and Kokkonen GC (1982) Dietary restriction and life extension – biological mechanisms. In: Moment GB (ed) Nutritional Approaches to Aging Research, 219–243. CRC Press, Boca Raton, FLGoogle Scholar
  7. Bartke A, Coschigano K, Kopchick J, Chandrashekkar V, Mattson J, Kinney B and Hauck S (2001) Genes that prolong life: relationships of growth hormone and growth to aging and lifespan. J Gerontol 56: B340–B349Google Scholar
  8. Berg BN and Simms HS (1965) Nutrition, onset of disease, and longevity in the rat. Can Med Assoc J 93: 911–913PubMedGoogle Scholar
  9. Bernarducci MP and Owens NJ (1996) Is there a fountain of youth? A review of current life extension strategies. Pharmacotherapy 16: 183–200PubMedGoogle Scholar
  10. Bodkin NL, Alexander TM, Ortmeyer HK, Johnson E and Hansen BC (2003) Mortality and morbidity in laboratory maintained Rhesus monkeys and effects of long-term dietary restriction. J Gerontol Biol Sci 58A: 212–221Google Scholar
  11. Brand-Miller JC, Holt SHA, Pawlak DB and McMillan J (2002) Glycemic index and obesity. Am J Clin Nutr 76(Suppl): 281S–285SGoogle Scholar
  12. Broe GA and Creasey H (1995) Brain ageing and neurodegenerative diseases: a major public health issue of the 21st century. Perspect Hum Biol 1: 53–58Google Scholar
  13. Cameron AJ, Welborn TA, Zimmet PZ, Dunstan DW, Owen N, Salmon J, Dalton M, Jolley D and Shaw JE (2003) Overweight and obesity in Australia: the 1999–2000 Australian diabetes, obesity and lifestyle study (AusDiab). Med J Aust 178: 427–432PubMedGoogle Scholar
  14. Carter CS, Ramsey MM, Ingram RL, Cashion AB, Cefalu WT, Wang ZQ and Sonntag WE (2002) Models of growth hormone and IGF-1 deficiency: application to studies of aging processes and life-span determination. J Gerontol 57: B177–B188Google Scholar
  15. Cooper MR, Stewart DC, Kahl FR, Brown WM and Cordell AR (2002) Medicine at the medical center then and now: one hundred years of progress. South Med J 95: 1113–1121PubMedGoogle Scholar
  16. Dhahbi JM, Kim H-J, Mote PL, Beaver RJ and Spindler SR (2004) Temporal linkage between the phenotypic and genomic responses to caloric restriction. Proc Natl Acad Sci USA 101: 5524–5529PubMedGoogle Scholar
  17. Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 348: 393–403Google Scholar
  18. Di Buono M, Hannah JS, Katzel LI and Jones PJ (1999) Weight loss due to energy restriction suppresses cholesterol biosynthesis in overweight, mildly hypercholesterolemic men. J Nutr 129: 1545–1548PubMedGoogle Scholar
  19. Doll R, Peto R, Boreham J and Sutherland I (2004) Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 326: 1519–1528Google Scholar
  20. Dunn SE, Kari FW, French J, Leininger JR, Travlos G, Wilson R and Barrett JC (1997) Dietary restriction reduces insulin-like growth factor 1 levels, which modulates apoptosis, cell proliferation, and tumor progression in p53 deficient mice. Cancer Res 57: 4667–4672PubMedGoogle Scholar
  21. Engeli S, Bohnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft F and Sharma AM (2005) Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45: 356–362PubMedGoogle Scholar
  22. Everitt AV (2003) Food restriction, pituitary hormones and ageing. Biogerontology 4: 47–50PubMedGoogle Scholar
  23. Everitt AV (2004) Can calorie restriction prolong life? Med Today 5: 91–92Google Scholar
  24. Everitt AV and Cavanagh LM (1963) The effect of chronic lung disease on the course of ageing in the male rat. Gerontologia 8: 1–15Google Scholar
  25. Ferruci L, Izmirlian G, Leveille S, Phillips CL, Corti MC, Brock DB and Guralnik JM (1999) Smoking, physical activity, and active life expectancy. Am J Epidemiol 149: 645–653PubMedGoogle Scholar
  26. Fontaine KR, Redden DT, Wang C, Westfall AO and Allison DB (2003) Years of life lost due to obesity. JAMA 289: 187–193PubMedGoogle Scholar
  27. Fontana L, Meyer TE, Klein S and Holloszy JO (2004) Long-term caloric restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci USA 101: 6659–6663PubMedGoogle Scholar
  28. Fraser GE and Shavlik DJ (2001) Ten years of life: is it a matter of choice? Arch Intern Med 161: 1645–1652PubMedGoogle Scholar
  29. Fujioka K (2002) Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical options. Obes Res 10(Suppl 2): 116S–123SPubMedGoogle Scholar
  30. Guyer B, Freedman MA, Strobino DM and Sondik EJ (2000) Annual summary of vital statistics: trends in the health of Americans during the 20th century. Pediatrics 106: 1307–1317PubMedGoogle Scholar
  31. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll IT, Vinarsky V, Bartholomew C and Ames BN (2002) Feeding acetyl-l-carnitine and lipoic acid to old rats significantly improves metabolic function, while decreasing oxidative stress. Proc Natl Acad Sci USA 123(425): 191–196Google Scholar
  32. Hansen BC and Bodkin NL (1993) Primary prevention of diabetes mellitus by prevention of obesity in monkeys. Diabetes 42: 1809–1814PubMedGoogle Scholar
  33. Heilbronn LK and Ravussen E (2003) Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr 78: 361–369PubMedGoogle Scholar
  34. Hipkiss AR, Brownson C and Carrier MJ (2001) Carnosine the anti-ageing, anti-oxidant dipeptide, may react with protein carbonyl groups. Mech Ageing Dev 122: 1431–1435PubMedGoogle Scholar
  35. Holloszy JO (1997) Mortality rate and longevity of food-restricted exercising male rats: a reevaluation. J Appl Physiol 82: 399–403PubMedGoogle Scholar
  36. Howitz KI, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielwski A, Zhang JJ, Scherer H and Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425: 191–196PubMedGoogle Scholar
  37. Hursting SD, Lavigne JA, Berrigan D, Perkins SN and Barrett JC (2003) Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Annu Rev Med 54: 131–152PubMedGoogle Scholar
  38. Ingram DK, Cutler RG, Weindruch R, Renquist DM, Knapka JM, April M, Belcher CT, Clark MA, Hatcherson CD, Marriott BM and Roth GS (1990) Dietary restriction and aging: the initiation of a primate study. J Gerontol Biol Sci 48: B148–B163Google Scholar
  39. Ingram DK, Ansom RM, De Caro R, Mamczarz J, Zhu M, Mattison J, Lane MA and Roth G (2004) Development of calorie restriction mimetics as a prolongevity strategy. Ann NY Acad Sci 1019: 412–423CrossRefPubMedGoogle Scholar
  40. Janssens H (2000) Endocrine aspects of ageing in men. Is hormone replacement of benefit? Eur J Obstet Gynecol Reprod Biol 92: 7–12CrossRefPubMedGoogle Scholar
  41. Kannel WB and Thom TJ (1984) Declining cardiovascular mortality. Circulation 70: 331–336PubMedGoogle Scholar
  42. Keenan KP, Smith PF and Soper KA (1994) Effect of dietary (caloric) restriction on aging, survival, pathology, and toxicology, in pathobiology of the aging rat. Int Life Sci Inst 2: 609–628Google Scholar
  43. Kitani K, Minami C, Yamamoto T, Kanai S, Ivy GO and Carrillo MC (2000) Pharmacological interventions in aging and age-associated disorders: potentials of propargylamines for human use. Ann NY Acad Sci 959: 295–307Google Scholar
  44. Lane MA, Ball SS, Ingram DK, Cutler RG, Engel J, Read V and Roth GS (1995) Diet restriction in rhesus monkeys lowers fasting and glucose-stimulated glucoregulatory endpoints. Am J Physiol 268: E941–E948PubMedGoogle Scholar
  45. Lane MA, Ingram DK and Roth GS (1999) Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular risk. Toxicol Sci 52(2 Suppl): 41–48PubMedGoogle Scholar
  46. Lane MA, Tilmont EM, DeAngelis H, Handy AM, Ingram DK, Kemnitz JW, Baum ST and Roth GS (2000) Short-term calorie restriction improves disease related markers in older male rhesus monkeys (Macaca mulatta). Mech Ageing Dev 112: 185–196CrossRefPubMedGoogle Scholar
  47. Lane MA, Mattison J, Ingram DK and Roth GS (2002) Caloric restriction and aging in primates: relevance to humans and possible CR mimetics. Microsc Res Tech 59: 335–338CrossRefPubMedGoogle Scholar
  48. Lane MA, Mattison JA, Roth GS, Brandt LJ and Ingram DK (2004) Effects of long-term diet restriction on aging and longevity in primates remains uncertain. J Gerontol Biol Sci 59A: 405–407Google Scholar
  49. Law MR, Wald NJ and Rudnicka AR (2003a) Quantifying effects of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326: 1423–1427CrossRefPubMedGoogle Scholar
  50. Law MR, Wald NJ, Morris JK and Jordan RE (2003b) Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 326: 1427–1431CrossRefPubMedGoogle Scholar
  51. Le Couteur DG, Fraser R, Cogger VC and McLean AJ (2002a) Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet 359: 1612–1615CrossRefPubMedGoogle Scholar
  52. Le Couteur DG, Muller M, Yang M, Mellick GD and McLean AJ (2002b) Age–environment and gene–environment interactions in the pathogenesis of Parkinson’s disease. Rev Environ Health 17: 51–64PubMedGoogle Scholar
  53. Le Couteur DG, Fraser R, Hilmer SN, Rivory LP and McClean AJ (2005) The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet 44: 187–200PubMedGoogle Scholar
  54. Linnane AW, Zhang C, Yarovaya N, Kopsidas G, Kovalenko S, Papakostopoulos P, Eastwood H, Graves S and Richardson M (2002) Human aging and global function of coenzyme Q10. Ann NY Acad Sci 959: 396–411PubMedGoogle Scholar
  55. Lipman RD, Dallah GE and Bronson RT (1999) Lesion biomarkers of aging in B6C3F1 hybrid mice. J Gerontol 54A: B466–B477Google Scholar
  56. Longo VD and Finch CE (2003) Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 299: 1342–1346CrossRefPubMedGoogle Scholar
  57. Masoro EJ (1995) Dietary restriction. Exp Gerontol 30: 291–298CrossRefPubMedGoogle Scholar
  58. Masoro EJ (2002a) Caloric Restriction: a Key to Understanding and Modulating Aging. Elsevier, AmsterdamGoogle Scholar
  59. Masoro ET (2002b) Mortality characteristics. In: Masoro ET (ed) Caloric Restriction: a Key to Understanding and Modulating Aging, pp 165–78. Elsevier, AmsterdamGoogle Scholar
  60. Masoro ET (2002c) Caloric restriction mimetics. Chapter. In: Masoro ET (ed) Caloric Restriction: a Key to Understanding and Modulating Aging, pp 165–78. Elsevier, AmsterdamGoogle Scholar
  61. Masoro EJ, McCarter RJM, Katz MS and McMahon CA (1992) Dietary restriction alters characteristics of glucose fuel use. J Gerontol 47: B202–B208PubMedGoogle Scholar
  62. McCay CM, Crowell MF and Maynard LA (1935) The effect of retarded growth upon the length of the lifespan and ultimate body size. J Nutr 10: 63–79Google Scholar
  63. McCormack J (2000) Hitting a century: centenarians in Australia. Aust J Ageing 19: 75–80Google Scholar
  64. McGinnis M and Foege WH (1993) Actual causes of death in the United States. JAMA 270: 2207–2212CrossRefPubMedGoogle Scholar
  65. McLean A and Le Couteur DG (2004) Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56: 163–184CrossRefPubMedGoogle Scholar
  66. Miller RD Jr and Frech HE (2000) Is there a link between pharmaceutical consumption and improved health in OECD countries? Pharmacoeconomics 18(Suppl 1): 33–45Google Scholar
  67. Mokdad AH, Marks JS, Stroup DF and Gerberding JL (2004) Actual causes of death in the United States, 2000. JAMA 291: 1263–1264CrossRefPubMedGoogle Scholar
  68. Morley JE (1999) Growth hormone: fountain of youth or death hormone? J Am Geriat Soc 47: 1475–1476PubMedGoogle Scholar
  69. Morley JE (2000) Diabetes mellitus: a major disease of older persons. J Gerontol Med Sci 55A: M255–M256Google Scholar
  70. Morley JE (2004) Is the hormonal fountain of youth drying up? J Gerontol Med Sci 59A: 458–460Google Scholar
  71. Must A, Spadano J, Coakley EH, Field AE, Colditz G and Dietz WH (1999) The disease burden associated with overweight and obesity. JAMA 282: 1523–1529CrossRefPubMedGoogle Scholar
  72. National Vital Statistics Reports (2004) Center for Disease Control and Prevention, Vol 52, # 13. Natl Ctr Health Stats, Hyattsville, MDGoogle Scholar
  73. Nawata H, Yanese T, Goto K, Okabe T and Ashida K (2002) Mechanism of action of anti-aging DHEA-S and the replacement of DHEA-S. Mech Ageing Dev 123: 1101–1106CrossRefPubMedGoogle Scholar
  74. OECD Health Data 2003 (2004) In: Tiffen R and Gittens R (eds) How Australia Compares, pp 210–211. Cambridge University Press, Cambridge, UKGoogle Scholar
  75. Paffenbarger RS, Hyde RT, Wing AL, Lee I-M, Jung DL and Kampert JB (1993) The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 328: 538–545CrossRefPubMedGoogle Scholar
  76. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xian XG, Cao HB, Liu PA, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH and Howard BV (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20: 537–544PubMedGoogle Scholar
  77. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamum A and Bonneux L (2003) NEDCOM, The Netherlands Epidemiology and Demography Comparison of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 138: 24–32PubMedGoogle Scholar
  78. Percheron G, Hogrel JY, Donot-Ledunois S, Fayet G, Foret G, Baulieu EE, Fardeau M and Marini JF (2003) Effect of 1-year oral administration of dehydroepi-androsterone to 60- to 80-year-old individuals on muscle function and cross-sectional area: a double blind placebo-controlled trial. Arch Intern Med 163: 720–727CrossRefPubMedGoogle Scholar
  79. Phillips PJ, Popplewell P and Wing L (2003) Diabetes and hypertension — double trouble. Med Today 4: 32–46Google Scholar
  80. Reaven GH (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75: 473–485PubMedGoogle Scholar
  81. Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM and Egger M (2004) Insulin-like growth factor (IGF)-1, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363: 1346–1353CrossRefPubMedGoogle Scholar
  82. Routledge PA, O’Mahony MS and Woodhouse KW (2003) Adverse drug reactions in elderly patients. Br J Clin Pharmacol 57: 121–126CrossRefGoogle Scholar
  83. Savo A, Maiorano PM, Onder G and Bernabei R (2003) Pharmacoepidemiology and disability in older adults: can medications slow the age-related decline in physical functions? Expert Opin Pharmacother 5: 407–413CrossRefGoogle Scholar
  84. Shibata H and Haga H (1992) Longevity. New Horizons in Aging Science, pp 31–33. University of Tokyo Press, TokyoGoogle Scholar
  85. Shimokawa I, Higami Y, Tsuchiya T, Otani H, Komatsu T, Chiba T and Yamaza H (2003) Life span extension by reduction of growth hormone-insulin like growth factor-1 axis: relation to calorie restriction. FASEB J 17: 1108–1109PubMedGoogle Scholar
  86. Simms HS and Berg BN (1962) Longevity in relation to lesion onset. Geriatrics 17: 235–242PubMedGoogle Scholar
  87. Slama M, Susic D and Frohlich ED (2002) Prevention of hypertension. Curr Opin Cardiol 17: 531–536CrossRefPubMedGoogle Scholar
  88. Sonntag WE, Lynch CD, Cefalu WT, Ingram RL, Bennett SA, Thornton PL and Khan AS (1999) Pleiotropic effects of growth hormone and insulin-like growth factor (IGF-1) on biological aging: inferences from moderate caloric-restricted animals. J Gerontol 54: B521–B538Google Scholar
  89. Sprott RL (1997) Diet and calorie restriction. Exp Gerontol 32: 205–214CrossRefPubMedGoogle Scholar
  90. Stamler J (1985) The marked decline in coronary heart disease mortality rates in the United States 1968–1981: summary of findings and possible explanations. Cardiology 72: 11–22PubMedGoogle Scholar
  91. Stunkard AJ (1976) Nutrition, aging and obesity. In: Rockstein M and Sussman ML (eds) Nutrition, Longevity and Aging, pp 253–284. Academic Press, New YorkGoogle Scholar
  92. Sytkowski PA, Kannel WB and D’Agostini RB (1990) Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med 322: 1635–1641PubMedGoogle Scholar
  93. Thurman JD, Bucci TJ, Hart RW and Turturro A (1994) Survival, body weight, and spontaneous neoplasms in ad libitum-fed and food-restricted Fischer-344 rats. Toxicol Pathol 22: 1–9PubMedGoogle Scholar
  94. Tjonneland A, Christensen J, Thomsen BL, Olsen A, Overvad K, Ewerts M and Melle L (2004) Hormone replacement therapy in relation to breast carcinoma incidence rate ratios: a prospective Danish cohort study. Cancer 100: 2326–2337Google Scholar
  95. Tuomiolehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Hanne-Parikka P, Keinanen-Kiukaanniemi S, Laakson M, Louheranta A, Rastas M, Salminen V and Uusitupa M (2001) Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344: 1343–1350CrossRefPubMedGoogle Scholar
  96. Turturro A, Witt WW, Lewis S, Hass B, Lipman RD and Hart RW (1999) Growth curves and survival characteristics of animals used in the Biomarker aging program. J Gerontol Biol Sci 54: B492–501Google Scholar
  97. United Nations 1955 (1957) United Nations Statistical Yearbook, pp 51–55. United Nations, New YorkGoogle Scholar
  98. Vallejo EA (1957) La dieta de hombre a dias alternos in a la alimentacion de los viejos. Rev Clin Exp 63: 25–49Google Scholar
  99. Vaupel JW, Carey JR, Christensen K, Johnson TE, Yashin AI, Holm NV, Lachine IA, Kannisto V, Khazaeli AA, Liedo P, Longo VD, Zeng Y, Manton KG and Curtsinger JW (1998) Biodemographic trajectories of longevity. Science 280: 855–860CrossRefPubMedGoogle Scholar
  100. Velthuis-te Wierik EJM, van den Berg H, Schaafsma G, Hendriks HFJ and Brouver A (1994) Energy restriction, a useful intervention to retard human ageing? Results of a feasibility study. Eur J Clin Nutr 48: 138–148PubMedGoogle Scholar
  101. Wainwright C (2005) Statins – is there no end to their usefulness? Cardiovasc Res 65: 296–298CrossRefPubMedGoogle Scholar
  102. Wald NJ and Law MR (2003) A strategy to reduce cardiovascular disease by more than 80%. BMJ 326: 1419–1423CrossRefPubMedGoogle Scholar
  103. Walford RL, Harris SB and Gunion MW (1992) The calorically restricted low-fat, nutrient dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol and blood pressure in humans. Proc Natl Acad Sci USA 98: 11533–11537Google Scholar
  104. Walford RL, Mock D, Verdery R and MacCallum T (2002) Calorie restriction in Biosphere 2: alterations in physiologic, hematologic, hormonal, and biochemical parameters in humans restricted for a 2-year period. J Gerontol Biol Sci 57A: B211–B224Google Scholar
  105. Walker J and Wynne H (1994) The frequency and severity of adverse drug reactions in elderly people. Age Ageing 23: 255–259PubMedGoogle Scholar
  106. Wathen CN, Feig DS, Feightner JW, Abramson BL and Cheung AM (2004) The Canadian Task Force on Preventive Health Care. Hormone replacement therapy for the primary prevention of chronic diseases: recommendation statement from the Canadian Task Force on Preventive Health Care. Can Med Assoc J 170: 1535–1537CrossRefGoogle Scholar
  107. Weindruch R and Sohal RS (1997) Caloric intake and aging. N Engl J Med 337: 986–994CrossRefPubMedGoogle Scholar
  108. Weindruch R and Walford RL (1988a) Retardation of Aging and Disease by Dietary Restriction. Charles C. Thomas, Springfield, ILGoogle Scholar
  109. Weindruch R and Walford RL (1998b) Prospects for retarding human aging by dietary restriction. Chapter 6. In: Weindruch R and Walford RL (eds) Retardation of Aging and Disease by Dietary Restriction, pp 295–337. Charles C. Thomas, Springfield, ILGoogle Scholar
  110. Willcox B, Willcox C and Suzuki M (2001) The Okinawa Way: How to Improve Your Health and Longevity Dramatically, pp 29. Michael Joseph, Penguin, LondonGoogle Scholar
  111. Willett W, Manson JA and Liu S (2002) Glycemic index, glycemic load, and risk of type 2 diabetes. Am J Clin Nutr 76(Suppl): 274S–280SPubMedGoogle Scholar
  112. Wilmoth JR (2000) Demography of longevity: past, present, and future trends. Exp Gerontol 35: 1111–1229CrossRefPubMedGoogle Scholar
  113. World Health Organization (2003) The World Health Report 2003. Shaping the Future, pp 146–153. WHO, Geneva, SwitzerlandGoogle Scholar
  114. Yu BP, Masoro EJ, Murata I, Bertrand HA and Lynd FT (1982) Life span study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass and disease. J Gerontol 37: 130–141PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Arthur V. Everitt
    • 1
    • 2
  • George S. Roth
    • 3
  • David G. Le Couteur
    • 1
  • Sarah N. Hilmer
    • 1
  1. 1.Centre for Education and Research on Ageing, ANZAC Research Institute, Concord HospitalUniversity of SydneySydneyAustralia
  2. 2.School of Medical SciencesUniversity of SydneySydneyAustralia
  3. 3.GeroScience Inc.PylesvilleUSA

Personalised recommendations